Print

BioMarker Strategies Names Dr. Samuel Broder to Board of Directors  
1/3/2011 9:37:42 AM

BALTIMORE--(BUSINESS WIRE)--BioMarker Strategies announced today that it has appointed three new Directors, including Dr. Samuel Broder, who is a former Director of the National Cancer Institute and Chief Medical Officer at Celera; Dr. Mark Velleca, a founder and former Senior VP of CGI Pharmaceuticals; and, Dr. Paul Beresford, currently the Vice-President of Business Development at Biodesix and former VP of Translational Diagnostics at Ventana Medical Systems.
//-->